NMERB
New Mexico Educational Retirement Board Portfolio holdings
AUM
$3.22B
1-Year Est. Return
25.35%
1 Year Est. Return
+25.35%
AUM
$3.06B
AUM Growth
+$275M
(+9.9%)
Holding
910
Top Buys
| 1 | +$3.36M | |
| 2 | +$3.19M | |
| 3 | +$2.55M | |
| 4 |
Capital One
COF
|
+$2.54M |
| 5 |
Pegasystems
PEGA
|
+$974K |
Top Sells
| 1 | +$2M | |
| 2 | +$1.96M | |
| 3 | +$1.66M | |
| 4 |
JWN
Nordstrom
JWN
|
+$560K |
| 5 |
Fortive
FTV
|
+$276K |
Sector Composition
| 1 | Technology | 30.43% |
| 2 | Financials | 14.37% |
| 3 | Consumer Discretionary | 11.13% |
| 4 | Industrials | 10.59% |
| 5 | Healthcare | 9.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Accenture
ACN
$181B
| $8.74M | 0.29% |
29,250
|
|
||
52
Verizon
VZ
$172B
| $8.51M | 0.28% |
196,771
|
|
||
53
PepsiCo
PEP
$207B
| $8.46M | 0.28% |
64,085
|
|
||
54
American Express
AXP
$264B
| $8.28M | 0.27% |
25,963
|
|
||
55
Qualcomm
QCOM
$192B
| $8.28M | 0.27% |
51,957
|
|
||
56
Morgan Stanley
MS
$283B
| $8.17M | 0.27% |
58,010
|
|
||
57
Adobe
ADBE
$147B
| $7.98M | 0.26% |
20,618
|
|
||
58
S&P Global
SPGI
$151B
| $7.85M | 0.26% |
14,886
|
|
||
59
Citigroup
C
$202B
| $7.53M | 0.25% |
88,426
|
|
||
60
Boston Scientific
BSX
$138B
| $7.4M | 0.24% |
68,862
|
|
||
61
Boeing
BA
$161B
| $7.31M | 0.24% |
34,895
|
|
||
62
Progressive
PGR
$139B
| $7.3M | 0.24% |
27,375
|
|
||
63
Charles Schwab
SCHW
$169B
| $7.27M | 0.24% |
79,687
|
|
||
64
Thermo Fisher Scientific
TMO
$216B
| $7.24M | 0.24% |
17,862
|
|
||
65
Blackrock
BLK
$168B
| $7.12M | 0.23% |
6,789
|
|
||
66
Honeywell
HON
$125B
| $7.08M | 0.23% |
30,386
|
|
||
67
Applied Materials
AMAT
$207B
| $7.05M | 0.23% |
38,486
|
|
||
68
Amgen
AMGN
$175B
| $7.01M | 0.23% |
25,095
|
|
||
69
GE Vernova
GEV
$185B
| $6.84M | 0.22% |
12,919
|
|
||
70
NextEra Energy
NEE
$170B
| $6.67M | 0.22% |
96,132
|
|
||
71
Eaton
ETN
$129B
| $6.59M | 0.22% |
18,460
|
|
||
72
Union Pacific
UNP
$143B
| $6.51M | 0.21% |
28,288
|
|
||
73
TJX Companies
TJX
$174B
| $6.5M | 0.21% |
52,680
|
|
||
74
Gilead Sciences
GILD
$149B
| $6.46M | 0.21% |
58,226
|
|
||
75
Pfizer
PFE
$145B
| $6.42M | 0.21% |
264,800
|
|